Neural Stem Cell-Derived Small Extracellular Vesicles: key Players in Ischemic Stroke Therapy – A Comprehensive Literature Review
DOI: https://doi.org/10.2147/ijn.s451642
IF: 7.033
2024-05-15
International Journal of Nanomedicine
Abstract:Zhihan Zhu, 1, &ast Qiankun Zhang, 1, &ast Jia Feng, 1 Sonia Zebaze Dongmo, 1 Qianqian Zhang, 1 Songze Huang, 1 Xiaowen Liu, 1 Guilong Zhang, 2 Lukui Chen 1 1 Department of Neurosurgery, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China; 2 Department of Neurosurgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lukui Chen, Department of Neurosurgery, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, People's Republic of China, Email Guilong Zhang, Department of Neurosurgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China, Email Ischemic stroke, being a prominent contributor to global disability and mortality, lacks an efficacious therapeutic approach in current clinical settings. Neural stem cells (NSCs) are a type of stem cell that are only found inside the nervous system. These cells can differentiate into various kinds of cells, potentially regenerating or restoring neural networks within areas of the brain that have been destroyed. This review begins by providing an introduction to the existing therapeutic approaches for ischemic stroke, followed by an examination of the promise and limits associated with the utilization of NSCs for the treatment of ischemic stroke. Subsequently, a comprehensive overview was conducted to synthesize the existing literature on the underlying processes of neural stem cell-derived small extracellular vesicles (NSC-sEVs) transplantation therapy in the context of ischemic stroke. These mechanisms encompass neuroprotection, inflammatory response suppression, and endogenous nerve and vascular regeneration facilitation. Nevertheless, the clinical translation of NSC-sEVs is hindered by challenges such as inadequate targeting efficacy and insufficient content loading. In light of these limitations, we have compiled an overview of the advancements in utilizing modified NSC-sEVs for treating ischemic stroke based on current methods of extracellular vesicle modification. In conclusion, examining NSC-sEVs-based therapeutic approaches is anticipated to be prominent in both fundamental and applied investigations about ischemic stroke. Keywords: neural stem cells, small extracellular vesicles, ischemic stroke, neuroprotection, neural regeneration Ischemic stroke refers to a clinical condition characterized by the sudden onset of neurological impairment resulting from a significant decrease or complete cessation of blood flow to the brain. 1 The main pathological manifestations observed in cases of ischemic stroke encompass substantial neuronal cell death, disruption of the axonal network, generation of reactive oxygen species and free radicals, production of cerebral oedema, impairment of the blood-brain barrier (BBB), and subsequent neuroinflammatory responses, ultimately resulting in the loss of local neural tissue and associated functionality. 2 The primary objective of clinical intervention for stroke is to promptly reinstate regional cerebral blood flow and minimize the occurrence and magnitude of impairment or dysfunction following stroke. 3 Nevertheless, irreversible damage to neural tissue often occurs due to the limited time window for therapy and secondary brain injury. 4 Furthermore, after reperfusion, the available neural cells remain inadequate for restoring and substituting necrotic functional neural tissue. NSCs have the multidirectional potential to differentiate into astrocytes, neurons, and oligodendrocytes. Over the past decades, NSCs have served as a valuable therapeutic modality for treating neurological diseases, providing new therapeutic tools and approaches for many refractory neurological diseases, 5,6 including ischemic stroke. 7 However, the quick clinical translation of transplanted NSCs has been hindered by concerns over their potential oncogenicity and immunological rejection. 8,9 Recent studies have revealed that paracrine effects (extracellular vesicles) are the predominant mode of action after stem cell transplantation, and extracting functional extracellular vesicles instead of NSC transplantation is promising to become a significant therapeutic approach. 10 Small extracellular vesicles (sEVs) are a kind of vesicles released through exocytosis and have a variety of biologically active components, including nucleic -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology